Legal Showdown Looms as States Prepare to Challenge Trump's AI Deregulation Order

A Federalism Battle Over AI in Healthcare

An unusual constitutional confrontation is brewing between the Trump administration and a bipartisan coalition of state governments over who controls the regulation of artificial intelligence in health insurance. This conflict, which scrambles traditional political alignments, is poised to become one of the defining federalism battles of 2026.

The Current Landscape

According to Articles 1-7 and 10-11, President Trump issued a December 2025 executive order seeking to preempt state AI regulation, declaring that "United States AI companies must be free to innovate without cumbersome regulation" and that "excessive State regulation thwarts this imperative." The administration frames this as essential to winning a "race with adversaries for supremacy" in a technological revolution. Meanwhile, states have been moving in the opposite direction. At least six states—Arizona, Maryland, Nebraska, Texas, Illinois, and California—have already enacted legislation restricting AI use in health insurance. Rhode Island and North Carolina are actively pursuing similar measures. Remarkably, this movement includes both Republican-led states like Florida (under Gov. Ron DeSantis) and Texas, as well as Democratic strongholds like Maryland. The federal government is simultaneously expanding AI integration into Medicare, experimenting with AI-powered prior authorization systems—the very applications that concern state regulators.

Key Trends and Signals

Several critical patterns emerge from this developing story: **Bipartisan State Resistance**: The fact that Republican governors like DeSantis are aligned with Democratic state governments against a Republican president signals that states view this as a fundamental sovereignty issue, not a partisan one. This suggests deeper institutional commitment than typical political opposition. **Consumer Protection Focus**: The North Carolina bill mentioned in the articles specifically targets AI being used as the "sole basis" for coverage decisions, indicating states are responding to constituent concerns about automated denials and lack of human oversight in healthcare decisions. **Momentum at State Level**: With six states having already passed legislation and more in the pipeline, there's clear momentum that predates Trump's executive order. States aren't backing down despite federal pressure. **Industry Implications**: The patchwork of state regulations creates compliance challenges for national insurers, giving them incentive to support federal preemption—aligning industry interests with the Trump administration's position.

Predicted Developments

### Legal Challenges Are Imminent Multiple states will file lawsuits challenging Trump's executive order within the next 2-3 months. Attorneys general from both parties will likely coordinate their legal strategies, similar to multi-state coalitions seen in previous federalism disputes. The constitutional questions are substantial: healthcare regulation has traditionally been a state domain, and executive orders have limited power to preempt state legislation without Congressional authorization. The legal challenges will focus on whether the executive order exceeds presidential authority and violates the 10th Amendment's reservation of powers to states. Expect states to argue that insurance regulation has been their traditional domain since the McCarran-Ferguson Act of 1945. ### Congressional Battle Lines Will Form Congress will become a secondary battleground, with some members attempting to codify either federal preemption or state authority through legislation. However, given the unusual political alignment—with some Republicans siding with states' rights and some Democrats (like Gov. Newsom) apparently supporting federal deregulation—traditional party-line votes will be difficult to achieve. This likely results in legislative gridlock, keeping the battle in the courts. ### More States Will Accelerate Legislation Rather than deterring state action, Trump's preemption attempt will likely accelerate it. States that were considering AI insurance regulations will rush to enact them before any federal preemption takes effect, wanting to establish their regulatory frameworks as existing law that's harder to overturn. Expect Florida, Rhode Island, North Carolina, and 5-10 additional states to introduce or pass AI insurance regulation bills by summer 2026. ### Enforcement Complications for Insurers National health insurers face a compliance nightmare. They cannot simply ignore state laws based on an executive order—doing so risks state-level enforcement actions, fines, and license revocations. Insurers will likely adopt a cautious approach, continuing to comply with state regulations while the legal battle unfolds, effectively limiting the practical impact of Trump's order in the near term. ### A Test Case Will Emerge One specific enforcement action—either a state penalizing an insurer for AI use that violates state law, or the federal government attempting to block state enforcement—will become the test case that reaches federal appeals courts. This will likely occur within 6 months, as both sides seek judicial clarity.

The Broader Implications

This conflict extends beyond AI and insurance. It represents a fundamental disagreement about innovation policy: whether rapid technological adoption or consumer protection should take precedence, and which level of government should make that determination. The outcome will establish precedents for regulating emerging technologies across multiple sectors. The Trump administration's framing of AI regulation as a national security issue—invoking competition with "adversaries"—is a strategic attempt to justify federal supremacy. However, states' focus on consumer protection in healthcare, an area where Americans have direct personal stakes, gives them powerful political ground to stand on. Given the strength of state institutional interests, bipartisan coalition, and traditional federalism principles around insurance regulation, the states are well-positioned in this fight. While the legal battle will be protracted, expect courts to be skeptical of broad executive branch claims to preempt state consumer protection laws without clear Congressional authorization.